SHSE:603520 (China)
Â
Class A
Â¥
9.29
(-0.11%)
Jul 16
Business Description
Zhejiang Starry Pharmaceutical Co Ltd
ISIN : CNE1000026N8
Share Class Description:
SHSE:603520: Class ACompare
Compare
Traded in other countries / regions
603520.China IPO Date
2016-03-09Description
Zhejiang Starry Pharmaceutical Co Ltd is engaged in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.17 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 1.77 | |||||
Debt-to-EBITDA | 19.75 | |||||
Interest Coverage | 1.97 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.21 | |||||
Beneish M-Score | -2.89 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.4 | |||||
3-Year EBITDA Growth Rate | -14.9 | |||||
3-Year EPS without NRI Growth Rate | -47.9 | |||||
3-Year Book Growth Rate | -1.3 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.05 | |||||
9-Day RSI | 42.84 | |||||
14-Day RSI | 40.66 | |||||
6-1 Month Momentum % | -21.31 | |||||
12-1 Month Momentum % | -37.71 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.77 | |||||
Quick Ratio | 0.41 | |||||
Cash Ratio | 0.19 | |||||
Days Inventory | 212.06 | |||||
Days Sales Outstanding | 61.7 | |||||
Days Payable | 101.04 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.15 | |||||
Dividend Payout Ratio | 1.05 | |||||
3-Year Dividend Growth Rate | 3.8 | |||||
5-Year Yield-on-Cost % | 4.88 | |||||
Shareholder Yield % | -5.4 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 24.64 | |||||
Operating Margin % | 8.97 | |||||
Net Margin % | 2.07 | |||||
FCF Margin % | -4.59 | |||||
ROE % | 2.67 | |||||
ROA % | 0.85 | |||||
ROIC % | 3.22 | |||||
ROC (Joel Greenblatt) % | 5 | |||||
ROCE % | 6.08 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 66.36 | |||||
PE Ratio without NRI | 48.64 | |||||
Shiller PE Ratio | 16.59 | |||||
PS Ratio | 1.34 | |||||
PB Ratio | 2.31 | |||||
Price-to-Tangible-Book | 3.89 | |||||
Price-to-Operating-Cash-Flow | 17.47 | |||||
EV-to-EBIT | 42.49 | |||||
EV-to-EBITDA | 42.49 | |||||
EV-to-Revenue | 2.95 | |||||
EV-to-FCF | -65.35 | |||||
Price-to-Projected-FCF | 5.99 | |||||
Price-to-Graham-Number | 2.89 | |||||
Earnings Yield (Greenblatt) % | 2.35 | |||||
FCF Yield % | -2.56 | |||||
Forward Rate of Return (Yacktman) % | 5.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang Starry Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 2,272.379 | ||
EPS (TTM) (Â¥) | 0.14 | ||
Beta | 1.46 | ||
Volatility % | 42.2 | ||
14-Day RSI | 40.66 | ||
14-Day ATR (Â¥) | 0.359648 | ||
20-Day SMA (Â¥) | 9.4775 | ||
12-1 Month Momentum % | -37.71 | ||
52-Week Range (Â¥) | 7.86 - 16.68 | ||
Shares Outstanding (Mil) | 438.41 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Zhejiang Starry Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Zhejiang Starry Pharmaceutical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Zhejiang Starry Pharmaceutical Co Ltd Frequently Asked Questions
What is Zhejiang Starry Pharmaceutical Co Ltd(SHSE:603520)'s stock price today?
The current price of SHSE:603520 is ¥9.29. The 52 week high of SHSE:603520 is ¥16.68 and 52 week low is ¥7.86.
When is next earnings date of Zhejiang Starry Pharmaceutical Co Ltd(SHSE:603520)?
The next earnings date of Zhejiang Starry Pharmaceutical Co Ltd(SHSE:603520) is .
Does Zhejiang Starry Pharmaceutical Co Ltd(SHSE:603520) pay dividends? If so, how much?
The Dividend Yield %  of Zhejiang Starry Pharmaceutical Co Ltd(SHSE:603520) is 2.15% (As of Today), Highest Dividend Payout Ratio of Zhejiang Starry Pharmaceutical Co Ltd(SHSE:603520) was 2. The lowest was 0.21. And the median was 0.45. The  Forward Dividend Yield % of Zhejiang Starry Pharmaceutical Co Ltd(SHSE:603520) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |